Who doesn’t love some new polling?

As part of today’s action, Data For Progress, a liberal think tank with the explicit goal of “challenging conventional wisdom about the American public that lack empirical support,” released a new poll in which nearly 85 percent of respondents supported letting Medicare negotiate over the price of drugs. (All told, they polled 1009 self-identified American voters, including Democrats, Republicans and Independents.)

The poll also shows sizeable support for “march-in rights,” which have been pushed by the most liberal wing of the Democratic party as a way to force drug makers to negotiate in good faith over their drug prices. Nearly 69 percent of those surveyed said they would support march-in rights “if the government determines that a drug company has raised prices beyond patients’ ability to pay” and just over 61% supported such a move in the event that “the government determines the price of the drug is higher in the United States than it is in other countries.”